Oscar Health Inc. Reports <a href="https://laohu8.com/S/QTWO">Q2</a> 2025 Revenue Surge to $2.86B, Net Loss of $228.4M, EPS Drops to $(0.89)
Oscar Health Inc. has released its financial results for the second quarter of 2025, reporting a total revenue of $2.86 billion, a significant increase from $2.22 billion in the same period of 2024. However, the company posted a net loss attributable to Oscar Health, Inc. of $228.4 million, compared to a net income of $56.2 million in the second quarter of 2024. The medical loss ratio rose to 91.1% from 79.0% in the previous year, while the SG&A expense ratio decreased to 18.7% from 19.6%. Oscar Health reported a loss from operations amounting to $230.5 million, compared to a gain from operations of $67.8 million in the second quarter of 2024. The company attributes the decrease to an increase in average market morbidity, resulting in a higher risk adjustment transfer accrual. Membership numbers for Oscar Health increased, with total membership reaching 2,027,148 as of June 30, 2025, up from 1,580,725 in the same period of the previous year. The Adjusted EBITDA showed a loss of $199.4 million for the second quarter of 2025, a downturn from a positive Adjusted EBITDA of $104.1 million in the second quarter of 2024.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oscar Health Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250806320230) on August 06, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.